icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
Prolonged RNA interference therapy with ARC-520 Injection in treatment na´ve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen
 
 
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
 
Man-Fung Yuen* 1, Kevin Liu1, Henry L. Chan2, Bruce D. Given3, Thomas Schluep3, James Hamilton3, Ching-Lung Lai1, Stephen A. Locarnini4, Johnson Y. Lau1, 5, Carlo Ferrari6, Robert G. Gish7, 8
1The University of Hong Kong, 2The Chinese University of Hong Kong, Hong Kong, Hong Kong, China, 3Arrowhead Pharmaceuticals, Pasadena, United States, 4Victorian Infectious Diseases Reference Laboratory, Victoria, Australia, 5Hong Kong Polytechnic University, Hong Kong, Hong Kong, China, 6University of Parma, Parma, Italy, 7Stanford University, Palo Alto, 8Hepatitis B Foundation, Doylestown, United States

0425171

0425172

0425173

0425174

0425175

0425176

0425177

0425178

0425179